COVID-19：武田 ､ノババックスと提携：年250百万回分ワクチン（動画）：
COVID-19: Partnership with Takeda､Novavax: 250 million vaccine per year：
COVID-19：与Takeda和Nova Bucks合作：每年生产2.5亿支疫苗
COVID-19：
武田薬品：
「ノババックス」と提携し、新型コロナウイルスのワクチンの製造技術の提供を受けることで基本合意しました。
山口県光市の工場：
武田薬品は山口県光市の工場に生産設備を準備。
厚生労働省から301億円の助成金も受けました。
日本国内向けのワクチンの開発と製造、流通を行うとしています。
生産能力の確保：
会社では年間で2億5000万回分以上のワクチンの生産能力を確保。
来年後半には最初のワクチンの製造にこぎつけ、国の承認を得たいとしています。
武田薬品が新型コロナウイルスのワクチンで企業と提携するのは初めて。
NHKニュース
Takeda teams up with Novavax to introduce its coronavirus vaccine in Japan
Takeda now has a vaccine project in its fight against the COVID-19 pandemic, alongside repurposing existing drugs and developing a plasma-based therapy to treat the deadly disease.
The Japanese pharma
reached a deal with Novavax to develop, manufacture and sell the U.S. biotech’s coronavirus vaccine candidate, NVX-CoV2373, in Japan.
While the exact monetary terms were not disclosed, the pair said Japan’s health authorities will help fund technology transfer, new infrastructure and scale-up of manufacturing. The goal is to build up capacity to produce 250 million doses of the shot a year.
“Takeda’s leading position in Japan, technical expertise, regulatory know-how and manufacturing capacity make the company an ideal partner to further expand the global availability of NVX‑CoV2373,” Novavax CEO Stanley Erck said in a statement.
RELATED: Novavax’s COVID-19 vaccine looks promising in early data
Data from the phase 1 portion of a phase 1/2 study
showed two consecutive doses of the recombinant shot triggered neutralizing antibodies at levels numerically higher than those seen in patients who had recovered from COVID-19.
A month ago, the Maryland biotech snared a $1.6 billion financial commitment from the U.S. government’s Operation Warp Speed to support the vaccine’s late-stage testing and manufacturing.
In return, the company pledged to deliver 100 million doses beginning as early as late 2020, with potentially more to come.
FiercePharma
https://www.fiercepharma.com/vaccines/novavax-takeda-team-up-to-introduce-covid-19-vaccine-to-japan